Emerging drugs for diabetic nephropathy

Area of Science:

• Nephrology
• Endocrinology
• Diabetology

Background:

• Diabetes mellitus is increasing globally, leading to a rise in diabetic kidney disease (DKD).
• DKD is a major cause of end-stage renal disease (ESRD) worldwide, posing significant medical and social challenges.
• Current medical interventions are inadequate for preventing DKD progression and development of ESRD.

Purpose of the Study:

• To highlight the urgent need for novel therapeutic approaches for diabetic nephropathy.
• To identify emerging molecular targets for the specific treatment of DKD based on recent pathogenetic insights.

Main Methods:

• Review of current understanding of DKD pathogenesis and progression.
• Identification of potential therapeutic targets from experimental studies.

Main Results:

• Several molecular targets, including aldosterone, aldose reductase, growth factors, and endothelin, have been identified for DKD treatment.
• Experimental models show promise in targeting these pathways to prevent DKD progression.

Conclusions:

• Despite promising experimental results, the clinical translation of novel therapeutic strategies for DKD remains limited.
• Further research and clinical trials are essential to develop effective treatments for diabetic nephropathy.